Redefining Pain and Addiction: How Opioid Manufacturers Changed Medical Language to Foster Opioid Use

Area of Science:

• Medical ethics
• Pharmaceutical marketing
• Public health

Background:

• The pharmaceutical industry's influence on medical discourse surrounding opioid use is not fully understood.
• Marketing strategies have permeated medical education, guidelines, and professional recommendations.
• Specific terminology has been strategically employed to shape perceptions of opioid therapy.

Purpose of the Study:

• To examine how pharmaceutical companies influenced medical discourse to promote opioid use.
• To analyze the impact of industry-generated terminology on the perception of opioid safety and efficacy.
• To investigate the reframing of opioid use disorder and its implications.

Main Methods:

• Analysis of industry-sponsored marketing messages in medical literature.
• Focus on specific industry-generated terms: "opiophobia," "pseudoaddiction," "breakthrough pain," and "pain is the 5th vital sign."
• Examination of the reframing of opioid dependence and tolerance.

Main Results:

• Industry-coined terms created a framework promoting opioid use for chronic pain.
• These terms fostered a false evidence base suggesting opioids were safe and effective.
• The reframing of opioid use disorder normalized risks and discouraged cautious prescribing.

Conclusions:

• Pharmaceutical marketing significantly influenced medical discourse, contributing to opioid overuse.
• Industry-driven terminology obscured the risks associated with long-term opioid therapy.
• The manipulation of medical language created a biased foundation for opioid prescribing practices.